Patent details

EP1180033 Title: LAMIVUDINE CONTAINING PHARMACEUTICAL FORMULATION

Basic Information

Publication number:
EP1180033
PCT Application Number:
PCT/JP/2000/002572
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP009173725
PCT Publication Number:
WO/2000/064427
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
LAMIVUDINE CONTAINING PHARMACEUTICAL FORMULATION
French Title of Invention:
FORMULATION PHARMACEUTIQUE CONTENANT DE LA LAMIVUDINE
German Title of Invention:
LAMIVUDIN ENTHALTENDE ARZNEIMITTEL
SPC Number:

Dates

Filing date:
20/04/2000
Grant date:
11/02/2004
EP Publication Date:
11/02/2004
PCT Publication Date:
02/11/2000
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
20/02/2002
EP B1 Publication Date:
11/02/2004
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
20/04/2004
Expiration date:
20/04/2020
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
20/04/2000
 
 

Name:
Glaxosmithkline Kabushiki Kaisha
Address:
6-15, Sendagaya 4-chome, Shibuya-ku, Tokyo, Japan (JP)

Inventor

1

Name:
MISHIMA Yasuhiro
Address:
Japan (JP)

2

Name:
SUGIBAYASHI Nobuya
Address:
Japan (JP)

3

Name:
MARUYAMA Toshio
Address:
Japan (JP)

4

Name:
KAWAMURA Koho
Address:
Japan (JP)

Priority

Priority Number:
9909154
Priority Date:
22/04/1999
Priority Country:
United Kingdom (GB)

Classification

Main IPC Class:
A61K 31/506;
Filing date Document type Number of pages